B1.3 OTHER Staphylococci Flashcards

S. epidermidis S. saprophyticus S. lugdunensis Other Coagulase-Negative Staphylococci Methicillin-Resistant Staphylococci aureus (MRSA) Vancomycin-Resistant Staphylococci Macrolide Resistance

1
Q

Other Staphylococci classifications

A

S. epidermidis
S. saprophyticus
S. lugdunensis
Other Coagulase-Negative Staphylococci
Methicillin-Resistant Staphylococci aureus (MRSA)
Vancomycin-Resistant Staphylococci
Macrolide Resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

indigenous microbiota of the skin
contaminant of medical instruments, catheters, CSF shunts and prosthetic heart valve implants (implanted medical devices), hip
prostheses

A

Staphylococcus epidermidis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Staphylococcus epidermidis disease caused

A

: Stitch abcess,
Health care-acquired UTIs,
Endocarditis,
Bacteremia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

In charge for the adherence of S. epidermidis

A

Poly-γ-DL-Glutamic Acid (PGA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

LABORATORY DIAGNOSIS used for detecting S. epidermidis

A

Blood agar plate
Biochemical Test
Susceptibility with 5-ug NOVOBIOCIN (16mm-27mm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Blood agar plate result for S. epidermidis

A

gray to white, opaque, small to medium-sized pinheads and non-hemolytic colonies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Biochemical test results for S. epidermidis

A

Coagulase (-),
CNA (+),
DNase(-),
Mannitol Fermentation (-)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

present on the normal skin and in the periurethral and urethral flora
adheres effectively to the epithelial cells lining the urogenital tract

A

Staphylococcus saprophyticus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Staphylococcus saprophyticus disease caused

A

common cause of UTI in young sexually active women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

significant result for urine culture in order to determine infection by S. saprophyticus

A

urine culture <10,000 CFU/ml

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

LABORATORY DIAGNOSIS used to determine S. saprophyticus

A

Blood agar plate
Biochemical test
Resistance to NOVONIOCIN (5ug; 6mm-12mm) and NALIDIXIC ACID
Absence of Phosphatase production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Blood agar plate result for S. saprophyticus

A

white, opaque, slightly larger than pin-heads, nonhemolytic colonies although some strains produce yellow pigments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Biochemical Test results for S. saprophyticus

A

Coagulase (-),
Dnase (-)
Mannitol Fermentation (-)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Staphylococcus lugdunensis results in coagulase test

A

clumping factor (+),
tube coagulase (-)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

contain mecA gene that encodes oxacillin resistance
more aggressive than other CoNS in inefectivity

A

Staphylococcus lugdunensis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Staphylococcus lugdunensis disease caused

A

infective endocarditis,
septicemia,
meningitis,
skin and soft tissue infections,
UTIs, and
septic shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Other Coagulase-Negative Staphylococci that causes endocarditis, septicemia, and wound infections

A

S. warneri,
S. capitis,
S. simulans,
S. hominis, and
S. schleiferi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Other Coagulase-Negative Staphylococci that causes wounds, bacteremia, endocarditis, and UTIs

medium-sized colonies, with moderate or weak hemolysis and variable pigment production

A

S. haemolyticus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

NOVOBIOCIN SUSCEPTIBLE CoNS

A

S. epidermidis
S. capitis
S. haemolyticus
S. hominis subsp. hominis
S. lugdunensis
S. saccharolyticus
S. warneri

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

NOVOBIOCIN RESISTANT CoNS

A

S. saprophyticus
S. cohnii
S. kloosii
S. xylosus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

RESISTANT GENES PRODUCED BY STAPHYLOCOCCI

A

a. Erythromycin Ribosomal Methylase (ERM) Gene

b. Methionine Sulfoxide Reductase (MSR) A Gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Class of enzyme inactivating genes
Codes for the methylation of the 23s rRNA
Results in resistance to erythromycin
Inducible or constitutive resistance to clindamycin
May not be detected in routine susceptibility testing
Confer cross-resistance to macrolides (erythromycin) and streptogramins (quinupristin)

A

Erythromycin Ribosomal Methylase (ERM) Gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Codes for efflux mechanism

A

Methionine Sulfoxide Reductase (MSR) A Gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

resistance to erythromycin but susceptibility to clindamycin

A

efflux mechanism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
type of S. aureus that is resistant to methicillin, nafcillin, and oxacillin  acquired after prolonged stay in the hospital, close contact with carriers, effects of broad spectrum antibiotic treatments and exposure to nasal secretions
Methicillin-Resistant Staphylococci aureus (MRSA)
26
treatment of choice for MRSA
VANCOMYCIN
27
Methicillin-Resistant Staphylococciaureus (MRSA) types
Community-Associated MRSA (CA-MRSA), Health Care–Associated Community-Onset (HACOMRSA), Hospital-Associated (HA-MRSA)
28
codes for altered Penicillin-Binding Protein (PBP) = PBP2a or PBP2′
mecA
29
LABORATORY DIAGNOSIS for identifying MRSA
a. OXACILLIN-SALT AGAR PLATE b. CHROMOGENIC TEST c. Latex Agglutination d. Molecular Nucleic Acid Probes or PCR Amplification
30
used to screen for MRSA in clinical samples differentiate MRSA from hyperproducers of β-lactamase, or Borderline Oxacillin-Resistant Staphylococcus aureus (BORSA)
OXACILLIN-SALT AGAR PLATE
31
Chromogenic Selective Differential Media:
MRSA Select, Spectra MRSA, CHROMagar MRSA
32
Substance used in chromogenic test that inhibits non-MRSA
CEFOXITIN
33
Results from CHROMOGENIC test for MRSA
Changes in color of MRSA colonies within 24 to 48 hours using CHROM Agar against colonies of non-MRSA
34
CHROM agar MRSA colonies color
Mauve-colored colonies
35
detect altered PBPs alternative method for testing and confirmation of oxacillin resistance  performed on both CoNS and S. aureus
Latex Agglutination
36
“gold standard” for MRSA detection
Molecular Nucleic Acid Probes or PCR Amplification
37
Vancomycin-Resistant Staphylococci screening used
Vancomycin Agar Plate
38
discrepant macrolide test results (erythromycin resistant and clindamycin susceptible)
MODIFIED DOUBLE DISK DIFFUSION TEST (D-zone test)
39
BETA-LACTAMASE TESTS types
Cephalosporinase Test Acidimetric Method Iodometric Method
40
uses cephalosporin or cefinase disk  Substrate: nitrocefin
Cephalosporinase Test
41
Cephalosporinase Test result for Staphylococci
 (+) result: deep pink or red color within 10 minutes (60 minutes for Staphylococci)
42
Acidimetric Method  Reagent:  pH indicator:  (+) result:
 Reagent: citrate-buffered penicillin  pH indicator: phenol red  (+) result: red  yellow (penicilloic acid = decrease pH)
43
Iodometric Method  Reagent:  (+) result:  (-) result:
 Reagent: citrate-buffered penicillin and starch iodine complex  (+) result: colorless solution- penicilloic acid reduces iodine and prevents it to combine with starch  (-) result: purple (no color change)8
44
ANTIMICROBIAL TESTING Treatment
methicillin, oxacillin, nafcillin, cloxacillin, and dicloxacillin (penicillinase-resistant penicllin drugs)
45
most commonly used treatment for Antimicrobial testing
Oxacillin
46
Cutaneous infections treatment used
oral oxaillin or dicloxacillin, if allergic, erythromycin may be substituted
47
Systemic infections treatment used
parenteral nafcilllin or oxacillin, if allergic, vancomycin or cephalosporin may be used
48
MRSA treatment used
vancomcin alone or in a combination with rifampicin
49
ANTIMICROBIAL TESTING types
A. Screening Test for MRSA: Oxacillin Screen Plate B. Cefoxitin Disk Diffusion (30 ug) C. Macro E Test D. Vancomycin Agar Screen Plate
50
A. Screening Test for MRSA: Oxacillin Screen Plate culture media used
MHA with 4% NaCl and 6 ug/mL oxacillin
51
Screening Test for MRSA: Oxacillin Screen Plate procedure
spot inoculated with cotton swab and incubated for 24 hours at 35°C
52
Microdilution Testing procedure for MRSA screening
oxacilin in cation-supplemented MH broth containing 2% NaCl
53
Result for Oxacillin Screen Plate for MRSA
Resistant- growth of more than one colony Susceptible- no growth on the agar plate
54
Result for Oxacillin Screen Plate for CoNS
 Resistant- 24 mm zone of inhibition  Susceptible- >25 mm zone of inhibition
55
Disadvantage of Oxacillin Screen Plate
Does not reliably detect oxacillin-resistant CoNS
56
preferred method for detection of oxacillin-resistance for both S. aureus and S. lugdunensis Improves detection of MRSA serves to induce greater PBP2a in mecA-containing strains Test reagent to detect resistance- both MIC and diffusion method
Cefoxitin Disk Diffusion (30 ug)
57
Cefoxitin Disk Diffusion (30 ug) interpretation
Resistant- < 21 mm Susceptible- > 22 mm
58
detection of heteroresistant VISA because the test uses a higher concentration of organisms (1 x 108 bacteria/ mL)
Macro E Test
59
best method for detection of either Vancomycin-resistant S. aureus (VRSA) or VISA
Vancomycin Agar Screen Plate
60
Vancomycin Agar Screen Plate S. aureus should be screened with
6-ug/mL vancomycin incorporated into BHIA
61
Confirmatory test for oxacillin resistance
Broth dilution and E-test